申联生物(688098.SH)发布前三季度业绩，归母净利润28万元，同比扭亏为盈

Core Insights - The company reported a revenue of 238 million yuan for the first three quarters of 2025, representing a year-on-year decline of 4.27% [1] - The net profit attributable to the parent company was 280,000 yuan, indicating a turnaround from a loss to profit year-on-year [1] - The company recorded a non-recurring net profit loss of 5.1 million yuan, with basic earnings per share reported as 0 yuan [1] Financial Performance - Revenue for the first three quarters: 238 million yuan, down 4.27% year-on-year [1] - Net profit attributable to the parent: 280,000 yuan, a year-on-year improvement [1] - Non-recurring net profit loss: 5.1 million yuan [1] - Basic earnings per share: 0 yuan [1]